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Arabidopsis and rice genomes [18]
suggests that lineage-specific
tinkering with the composition of
the plastid proteome can occur
even over short evolutionary
timescales.
In the mean-time, multiple algal
genome sequences are now
publicly available — for example,




red alga Cyanidioschyzon (http://
merolae.biol.s.u-tokyo.ac.jp) —
and it is likely that ten or more plant
and algal nuclear genome
sequences will be available for
even more thorough and
systematic analyses within the next
few years. An increasing number
of genomes from ‘secondary’
plastid-containing algae such as
diatoms, cryptophytes and
chlorarachniophytes will also be
completely sequenced (http://
www.jgi.doe.gov/). These
organisms acquired their plastids
through the engulfment of red or
green algal endosymbionts [19]
and the molecular dynamics
accompanying the process
of secondary endosymbiosis, in
which gene transfers between
evolutionarily distinct nuclear
genomes are also a possibility,
adds another layer of complexity to
an already complicated picture
[20]. Overall, it is sobering to
consider how little we know about
the nuts and bolts of
endosymbiosis and the full scope
of its role in the diversification of
eukaryotic cells.
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Misfolded proteins in the ER require the p97 AAA ATPase for dislocation
across the membrane prior to degradation by the cytosolic proteasome.
The mechanism by which dislocated proteins are delivered to the
proteasome from p97 is unclear, but recent studies suggest an
important regulatory role for the protein ataxin-3.Colin J. Stirling1
and J. Michael Lord2
The fatal neurodegenerative
Machado-Joseph disease, also
known as spinocerebellar ataxia
type 3, is caused by mutations of
the polyglutamine-containing
protein ataxin-3 [1]. The
biochemical properties of
ataxin-3 are well known, but
its physiological role has been
elusive. Two recent studies [2,3]
now implicate ataxin-3 in the
process known as endoplasmic-
reticulum-associated degradation(ERAD), suggesting a link
between endoplasmic
reticulum (ER) stress and the
neuropathology associated
with disease.
After targeting to the ER,
proteins are screened by a quality
control system to prevent
misfolded forms from progressing
through the secretory pathway.
Rather than accumulating within
the cell, these aberrant proteins
are disposed of by ERAD. This
requires the dislocation of such
proteins across the ER membrane
and their subsequent degradation
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R1036by the cytosolic proteasome
system. The precise nature of the
membrane channel through which
dislocation occurs is not yet
known, but a number of proteins
have been implicated, including
Sec61, Derlin-1 and VIMP [4].
However, evidence suggests
that the hexameric AAA ATPase
p97/VCP (known as Cdc48 in
yeast) plays an important role in
driving the dislocation of a range
of proteins [5–8]. A complex
comprising p97, and the
adaptor proteins Ufd1 and Npl4,
is recruited to the cytosolic face
of the ER membrane, where it is
believed to ‘pull’ dislocating
polypeptides through the channel
and into the cytosol.
During their dislocation, ERAD
substrates are normally
polyubiquitinated, and the p97
complex has been shown to bind
directly to these polyubiquitin
chains. A further set of
polyubiquitin-binding proteins,
including Rad23p and Dsk2p, are
associated with the proteasome,
where they function in the final
delivery of the ERAD substrate to
the degradation machinery [9].
The mechanism by which an ERAD
substrate is transferred from the
p97 complex to proteasomal
polyubiquitin-binding proteins is
not known. Previous studies have
shown that ataxin-3 can interact
with both p97/VCP and Rad23p
[10,11], and two recent papers
[2,3] suggest that ataxin-3 is
a critical link in this chain.
Wang et al. [2] and Zhong and
Pittman [3] have studied the effects
of the expression of wild-type and
mutant forms of ataxin-3 on a range
of ERAD substrates. Both studies
confirm that full-length ataxin-3
binds directly to p97, but
ataxin-3 was also found in
a membrane-associated form that
could be co-immunoprecipitated
together with several other ERAD
components, including Derlin-1,
VIMP and the ER-specific ubiquitin
ligase Hrd1p [2]. Previous studies
have shown that ataxin-3 has three
functional ubiquitin-interacting
modules plus a deubiquitinating
activity [12–15].
These new studies [2,3] provide
evidence that ataxin-3, and
specifically its deubiquitinating
activity, are required in ERAD. Theataxin-3 C14A mutant lacks the
catalytic deubiquitinating activity
but is still able to bind ubiquitinated
substrates with high affinity.
Ectopic expression of ataxin-3
C14A in transfected cells led to
the accumulation of typical ERAD
substrates, including TCRa,
a membrane component of the
T-cell receptor which is degraded
in the absence of other T-cell
receptor subunits. The
accumulated forms of TCRa were
found to be extensively
polyubiquitinated in atx C14A cells,
suggesting a role for ataxin-3 in
the deubiquitination of substrate
during the normal ERAD process.
This was further confirmed by
the demonstration that p97-bound
substrate could be deubiquitinated
in vitro in the presence of wild-type
ataxin-3 but not the C14A mutant.
Consistent with this, Wang et al. [2]
further demonstrated a dramatic
increase in the amount of
ubiquitinated proteins that could
be co-immunoprecipitated with
p97in ataxin-3 C14A cells
compared to controls. Zhong and
Pittman [3] further examined the
effect of pathological mutations in
the polyglutamine tract of ataxin-3.
Their studies show that mutant
ataxin-3 binds p97/VCP more
avidly than the wild-type protein,
and this correlates with
decreased degradation of the
ERAD substrate CD3d [3]. These
studies suggest that the pathology
of ataxin-3 mutants relates to
defective ERAD.
Taken together, the new data
[2,3] indicate that ataxin-3 plays
a critical role in the p97-associated
degradation of ERAD substrates,
and that this is necessary for the
efficient release of substrate from





proteins and so it is proposed
that ataxin-3 might function as
an ‘editing enzyme’ that merely
shortens polyubiquitin chains.
In this model the normal
deubiquitinating activity of ataxin-3
would trim polyubiquitin chains to
a level that allows their release
from the p97 complex, but still
permits binding to crucial
proteasomal components.Interestingly, the ubiquitin chains
of ERAD substrates in
Saccharomyces cerevisiae are
progressively shortened as they
transit to the proteasome [16].
Such a role for mammalian ataxin-3
would require tight regulation since
any change in the level of
deubiquitinating activity might be
expected to perturb ubiquitin
trimming and thus prevent
efficient transfer of substrates
to the proteasome. Indeed,
ectopic over-expression of even
wild-type ataxin-3 resulted in the
accumulation of TCRa and CD3d
[2,3], suggesting that this molecule
is an important regulator of
mammalian ERAD.
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A signaling pathway involving two pr
restricts the growth of imaginal discs
taken together show that the protoca
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Iswar K. Hariharan
Genetic studies in Drosophila have
led to the identification of
a signaling pathway, sometimes
referred to as ‘the Hippo pathway’,
that appears to be important in
regulating tissue growth (reviewed
in [1,2]). Inactivating mutations in
several components of this
pathway result in a dramatic
overgrowth of mutant tissue in the
imaginal discs — sacs of epithelial
tissue found in the larva that
eventually become adult structures
such as the eye, wing and leg. Each
component of the Hippo pathway
identified to date has one or more
mammalian orthologs that
probably function in an analogous
manner to their Drosophila
counterparts. Thus, this pathway is
likely to have a role in diverse
species in the determination of the
overall size of individual organs.
Evidence is also accumulating to
show that altered signaling via this
pathway can contribute to the
development of cancer in
mammals [2–4].
At the core of this pathway
(reviewed in [1,2]), is a module
composed of two protein kinases,
Hippo and Warts. Hippo,
amember of the Ste20 superfamily,
acts upstream of Warts, a member
of the nuclear Dbf2 related (NDR)
family of protein kinases, and
activates it by directCamilli, P. (2005). Deubiquitinating
function of ataxin-3: insights from the
solution structure of the Josephin domain.
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otein kinases, Hippo and Warts,
in Drosophila. Four recent studies
dherin Fat can regulateWarts in two
phosphorylation. Hippo-mediated
Warts activation is facilitated by
Salvador, aWWdomain-containing
protein that probably functions as
a scaffold, and also by Mats,
a protein that binds directly to
Warts. When activated, Warts can
phosphorylate a transcriptional
co-activator, Yorkie [5] and reduce
its activity, possibly by excluding it
from the nucleus. Yorkie promotes,
either directly or indirectly, the
transcription of genes that promote
growth and cell-cycle progression
as well as genes that inhibit
apoptosis. Thus, increased activity
of Hippo and Warts correlates with
a reduction in tissue growth and
a reduction of Hippo/Warts activity
allows growth to occur.
Given the obvious importance of
the Hippo pathway in regulating
tissue growth, a gaping hole in our
understanding of its role in
organismal development has been
the inability to correlate the level
of activation of this pathway
with any known physiological
parameter. In contrast, the
activity of many other growth
regulators can be stimulated by
extracellular growth factors (e.g.
phosphatidylinositol 3-kinase) or
the availability of nutrients (e.g.
Tor). A possible role for the Hippo
pathway was suggested by the
finding that two proteins with four
point one, ezrin, radixin, moesin
(FERM) domains, Merlin andmultiubiquitination and proteasomal
targeting. Cell 120, 73–84.
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redundantly as activators of Hippo
[6]. Proteins with FERM domains
are thought to link the cortical
cytoskeleton with integral
membrane proteins [7], leading to
speculation that they, and hence
the Hippo pathway, may function
to inhibit tissue growth in response
to increased cell density or
possibly even mechanical
stresses.
Four recent studies [8–11], three
published in Current Biology and
one in Nature Genetics all implicate
the protocadherin Fat [12,13] as an
activator of the Hippo pathway.
Linking Fat to the Hippo pathway
represents an important
development, since it is the first
evidence that the activity of the
Hippo pathway can potentially be
regulated by an extracellular signal
that is most likely a ligand
expressed on the surface of an
adjacent cell. While it has been
known for many years that
inactivating mutations in fat result
in increased tissue growth, the
reason for the increase in growth
was not known. By analyzing the
expression of transcriptional
targets of the Hippo pathway, the
authors of all four studies conclude
that cells that are mutant for fat
resemble, in several ways, cells
that have inactivating mutations in
hippo or warts. Importantly,
however, the studies differ in their
explanations for how Fat can
regulate signaling via the Hippo
pathway and propose two distinct
models of Fat function. As will be
discussed below, it is likely that Fat
can regulate the Hippo pathway in
both of these ways, but their
relative importance under
physiological conditions has yet to
be determined.
